Applied DNA Sciences Inc - SIC # 2893 - PRINTING INK

Ticker Exchange SIC # Website Latest Ticker
APDN Nasdaq 2893 http://www.adnas.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Applied DNA Sciences Inc

Applied DNA Signs Term Sheet with TheraCann International for Exclusive License of CertainT® Platform in Legal Cannabis and Hemp - Feb 12th, 2019 3:00 am
Edited Transcript of APDN earnings conference call or presentation 7-Feb-19 9:30pm GMT - Feb 11th, 2019 3:15 pm
Applied DNA Sciences: Fiscal 1Q Earnings Snapshot - Feb 7th, 2019 4:02 pm
Applied DNA Reports Fiscal First Quarter 2019 Financial Results - Feb 7th, 2019 2:05 pm
Joint Applied DNA/TheraCann’s Cannabis Seed-to-Sale Solution Positioned Towards Europe, Africa and Asia Markets by Israel Cannabis (iCAN) - Feb 6th, 2019 1:46 pm
Applied DNA Schedules Fiscal 2019 First Quarter Financial Results Conference Call for Thursday, February 7, 2019 at 4:30 PM ET - Jan 31st, 2019 3:00 am
Applied DNA Appoints Stephen Birkhold to the Strategic Advisory Board - Jan 29th, 2019 3:00 am
Applied DNA Signs MOU with Tex-Ray Industrial to Introduce CertainT® Authentication Platform to Global Textile Brands - Jan 28th, 2019 3:00 am
Applied DNA Signs Memorandum of Understanding with Sun Chemical Supply Company to Bring CertainT® Authentication Platform to Textile Manufacturers in Asia - Jan 24th, 2019 3:00 am
Applied DNA Announces Closing of $2.75 Million Public Offering of Common Stock and Warrants - Dec 27th, 2018 2:05 pm
Applied DNA Announces Pricing of $2.75 Million Offering of Common Stock and Warrants - Dec 21st, 2018 6:30 am
Applied DNA Announces Proposed Public Offering of Common Stock and Warrants - Dec 19th, 2018 2:06 pm
Applied DNA Announces Selected Preliminary Unaudited Fiscal 2018 Year End and Fourth Quarter Financial Results - Dec 13th, 2018 5:00 am
Applied DNA Signs Joint Development Agreement with Everledger to Develop and Market a CertainT®-Enhanced, Blockchain-Based Platform for Provenance Verification - Dec 10th, 2018 3:00 am
Applied DNA to Participate at Cannabis Capital Forum on December 7 - Dec 6th, 2018 6:30 am
LineaRx to Hold Analyst Day Webinar to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy - Dec 4th, 2018 10:28 am
What Type Of Shareholder Owns Applied DNA Sciences Inc’s (NASDAQ:APDN)? - Dec 1st, 2018 6:59 am
Applied DNA’s SigNature® DNA Evidence Helps to Convict Over 131 Criminals to Date - Nov 26th, 2018 3:00 am
Long Island Capital Alliance to Hold Cannabis Capital Forum on December 7, 2018 - Nov 21st, 2018 6:00 am